S1815- A Phase III Randomized Trial Of Gemcitabine, Cisplatin, And Nab-Paclitaxel Versus Gemcitabine And Cisplatin In Newly Diagnosed, Advanced Biliary Tract Cancers
Posted Date: Oct 1, 2019
- Investigator: Olugbenga Olowokure
- Specialties: Cancer, Oncology
- Type of Study: Drug
The purpose of this study is to compare overall survival (OS) in patients with untreated, advanced biliary cancers treated with gemcitabine and cisplatin (GC) versus those treated with gemcitabine, cisplatin, and nab-Paclitaxel (GCN)
Criteria:
To Be Eligible: Must Be Diagnosed With Intra Or Extrahepatic Cholangiocarcinoma Or Gallbladder Cancer, >18 Years Of Age, Nonpregnant/Nonbreastfeeding, No Other Active Infection
Keywords:
Gallbladder Cancer, Oncology, Biliary Cancer
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com